How to better diagnose cognitive health? Up size and variety of drawing tasks, study shows
By
Alicia Lasek
Jul 01, 2022
Clinicians can more accurately classify a patient’s cognitive health status by increasing the number and variety of diagnostic drawing tasks, investigators report.
Clinical briefs for Tuesday, June 21
By
Alicia Lasek
Jun 21, 2022
App may improve meds adherence among seniors with mild cognitive impairment … Maine, Hawaii top list of states’ pandemic healthcare performance … COVID-19 vaccine hesitancy spills into adults’...
Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
By
Alicia Lasek
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.
Smartphone technology helps seniors with mild dementia complete daily tasks, study finds
By
Alicia Lasek
Nov 18, 2021
Despite the pervasive notion that older adults dislike technology, participants enjoyed learning to use smartphone memory apps and were able to improve their daily prospective memory performance over four...
Listening to favorite music may improve cognitive function of Alzheimer’s patients
By
Alicia Lasek
Nov 10, 2021
Music that holds a special meaning stimulates the brains of Alzheimer’s patients in key areas, a new study finds. The results support personalized, music-based interventions for people with dementia,...
Donepezil may help preserve muscle cell functioning in Alzheimer’s
By
Alicia Lasek
Sep 28, 2021
People with early Alzheimer’s who are treated with the drug donepezil maintain mitochondrial function in their muscles when compared to their untreated peers, researchers report.
First appropriate use guidance published for Alzheimer’s drug Aduhelm
By
Alicia Lasek
Jul 28, 2021
The new guidelines cover how to choose appropriate patients, safely scale up to a full dose, monitor side effects and assess effectiveness. The authors also address when to stop therapy and what patients...
FDA limits use of new dementia drug Aduhelm to mild cognitive impairment only
By
Alicia Lasek
Jul 09, 2021
The FDA’s new label restricts Aduhelm’s use to Alzheimer’s patients with mild cognitive impairment or mild dementia, drugmaker Biogen announced Thursday.
Clinical briefs for Wednesday, July 7
By
Alicia Lasek
Jul 07, 2021
One year of aerobic exercise may stave off decline in mild cognitive impairment … Benefits of mRNA vaccine outweigh adverse heart event risks, CDC researchers conclude … Alzheimer’s Association pushes...